President Interview|Ms. Song Qingchun, President and Founder of Spring Proswell, Accepts an Interview with "Pharma Tech Outlook"

In March 2021, Ms.

Proswell: Driving Innovation for Clinical Trials across China

Spring Proswell: Promoting China's Clinical Trial Innovation

“As a doctor, I know that the patient recovery, prognosis, and duration of therapy depends on more than good medical skills and experience; the most important part of the healing process remains to be high-quality medicine for treatment ”

--- Dr.

"As a doctor, I know that the patient's recovery, prognosis, and duration of treatment do not only depend on good medical skills and experience; the most important part of the healing process is still high-quality therapeutic drugs.

--- Song Qingchun, founder and president of Proswell

At the end of the 1990s, countries around the world began to gradually combine modern innovative technologies with medicine.

As a doctor, Ms.

Proswell in the Spring Proswell brand word is a combination of the words "prosperous" and "well" Pros and well.

Spring Proswell supports customers through effective organization and clinical trials in the main therapeutic areas of oncology, respiratory medicine, ophthalmology, neurology and anesthesiology.

In order to better clarify the service capabilities of Spring Proswell, Ms.

Spring Proswell is in a dominant position in the Asia-Pacific market with its continuously enterprising and innovative attitude in the CRO field.